Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
01/04/1996 | WO1996000232A1 RIBOZYMES WITH OPTIMIZED HYBRIDIZING ARMS, STEMS, AND LOOPS, tRNA EMBEDDED RIBOZYMES AND COMPOSITIONS THEREOF |
01/04/1996 | WO1996000084A1 Use of autoantibodies for tumor therapy and prophylaxis |
01/04/1996 | WO1996000006A1 Inducible nitric oxide synthase gene for treatment of disease |
01/04/1996 | WO1995033059A3 Receptor for oncostatin m |
01/04/1996 | WO1995033055A3 Wax esters in transformed plants |
01/04/1996 | WO1995030018A3 Recombinant poxviruses with foreign polynucleotides in essential regions |
01/04/1996 | WO1995029193A3 Melanoma antigens |
01/04/1996 | DE4422667A1 Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen Process for the preparation and culturing of hematopoietic progenitor cells |
01/04/1996 | CA2193827A1 Inducible nitric oxide synthase gene for treatment of disease |
01/04/1996 | CA2193373A1 Ribozymes with optimized hybridizing arms, stems, and loops, trna embedded ribozymes and compositions thereof |
01/04/1996 | CA2192091A1 Heat-stable prolylendopeptidase |
01/04/1996 | CA2170156A1 Protocadherin proteins and their uses |
01/03/1996 | EP0690127A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
01/03/1996 | EP0690125A2 Process for induction culture of cytotoxict lymphocytes having killing activity against tumor cells |
01/03/1996 | EP0690071A2 Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase |
01/03/1996 | EP0689606A1 ANTIBODIES AND ASSAYS FOR DETERMINING MUTATIONS IN THE $i(APC) GENE |
01/03/1996 | EP0689605A1 Hepatitis b escape mutant specific binding molecules |
01/03/1996 | EP0689604A1 Process for preparing cancer vaccines |
01/03/1996 | EP0689602A1 Delivery system controlled through factors associated with hiv and cell |
01/03/1996 | EP0689601A1 Production of high titer helper-free retroviruses by transient transfection |
01/03/1996 | EP0689600A1 Process to induce the death of tumor cells |
01/03/1996 | EP0689599A1 Chimeric selectin by exchange of domains - uses thereof |
01/03/1996 | EP0689597A1 USE OF PORCINE GAL $g(a)(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES |
01/03/1996 | EP0689596A1 Stimulation of immune response by viral protein |
01/03/1996 | EP0689594A1 Dna, dna constructs, cells and plants derived therefrom |
01/03/1996 | EP0689593A1 Inhibition of selected tumor growth with recombinant viral sector |
01/03/1996 | EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
01/03/1996 | EP0689589A1 Oxidatively stable alpha-amylase |
01/03/1996 | EP0689588A1 Extracellular signal-regulated kinase, sequences, and methods of production and use |
01/03/1996 | EP0689552A1 A method of detecting rupture of the amniotic membranes in pregant mammals |
01/03/1996 | EP0689551A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
01/03/1996 | EP0689550A1 Novel antimicrobial peptides from bovine neutrophils |
01/03/1996 | EP0689547A1 Cloned human alpha1c adrenergic receptor |
01/03/1996 | EP0689447A1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
01/03/1996 | EP0626012A4 Homogenotization of gene-targeting events. |
01/03/1996 | EP0473701B1 Recombinant dna method for production of parathyroid hormone |
01/03/1996 | CN1114357A Process for producing recombinative polypeptide using transgene animal |
01/03/1996 | CN1114355A DNA amplification |
01/02/1996 | US5480968 Isolated polypeptide erbB-3, related to the epidermal growth factor receptor and antibody thereto |
01/02/1996 | US5480956 Feline interferon and process for production thereof |
01/02/1996 | US5480827 Use of porous polycrystalline aragonite as a support material for in vitro culture of cells |
01/02/1996 | US5480825 AG-F human T cell line with unique phenotype and cytokine secretions |
01/02/1996 | US5480796 Antibodies against the receptor protein for human B cell stimulatory factor-2 |
01/02/1996 | US5480789 Genetically transformed rose plants and methods for their production |
01/02/1996 | US5480782 Process for obtaining cellular protein having anti-HIV activity |
01/02/1996 | US5480772 Separation of nucleus from erythrocytes using protease and nonionic detergents, contacting with cytostatic factor extract and pretreatment with activating egg extract |
12/28/1995 | WO1995035501A1 Cell calcium regulation and its use |
12/28/1995 | WO1995035500A1 Method for producing cytolytic t cells specific for a complex of peptide and mhc-molecule |
12/28/1995 | WO1995035375A1 Interleukin-5 specific recombinant antibodies |
12/28/1995 | WO1995035372A1 5-lipoxygenase-activating protein ii |
12/28/1995 | WO1995035320A1 High-affinity melatonin receptors and uses thereof |
12/28/1995 | WO1995035120A1 Monoclonal antibodies for the reduction of anti-xenogeneic immune responses |
12/28/1995 | WO1995035118A1 Contraceptive vaccine |
12/28/1995 | WO1995035026A1 Novel plants and processes for obtaining them |
12/28/1995 | WO1995035024A1 Plant virus resistance gene and methods |
12/28/1995 | WO1995033818A3 Genes for the synthesis of antipathogenic substances |
12/28/1995 | CA2193206A1 Contraceptive vaccine |
12/28/1995 | CA2193205A1 High-affinity melatonin receptors and uses thereof |
12/28/1995 | CA2193123A1 Plant virus resistance gene and methods |
12/28/1995 | CA2192562A1 Method for producing cytolytic t cells specific for a complex of peptide and mhc-molecule |
12/28/1995 | CA2190761A1 Novel plants and processes for obtaining them |
12/27/1995 | EP0688869A1 Novel osteoinductive compositions |
12/27/1995 | EP0688430A1 Immobilisation and separation of cells and other particles |
12/27/1995 | EP0688361A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
12/27/1995 | EP0688358A1 Improved vectors for gene therapy |
12/27/1995 | EP0688334A1 Oligodendroglial trophic factor and methods of use thereof |
12/27/1995 | EP0688227A1 Production of human papillomavirus capsid protein and virus-like particles |
12/27/1995 | EP0688223A1 $i(IN VITRO) ASSAY MEASURING DEGREE OF ACTIVATION OF IMMUNE CELLS |
12/27/1995 | EP0688196A1 Ported tissue implant systems and methods of using same |
12/27/1995 | EP0607178A4 Methods for the selection, separation and fusion of cells. |
12/27/1995 | EP0584184A4 System and process for supporting hematopoietic cells |
12/27/1995 | EP0579596B1 Cell culture medium and method for preparing such medium |
12/27/1995 | EP0419621B1 Process for the specific replacement of a copy of a gene present in the receiver genome via the integration of a gene |
12/26/1995 | US5478926 Monoclonal antibody against human IgE |
12/26/1995 | US5478925 Peptides which block the binding of Tumor Necrosis Factor to its receptors |
12/26/1995 | US5478739 Three-dimensional stromal cell and tissue culture system |
12/26/1995 | US5478369 Nucleotide sequences mediating male fertility and method of using same |
12/26/1995 | CA1337800C Monoclonal antibody recognizing alpha 2 --> 3 bonds |
12/24/1995 | CA2152426A1 Crucifer aft proteins and uses thereof |
12/21/1995 | WO1995034817A1 Positive and positive/negative cell selection mediated by peptide release |
12/21/1995 | WO1995034676A1 Population of cells enriched for myeloid and/or lymphoid progenitors and methods of making and using |
12/21/1995 | WO1995034671A1 Complementary adenoviral vector systems and cell lines |
12/21/1995 | WO1995034670A2 Recombinant aav genome encoding immunodeficiency virus protein |
12/21/1995 | WO1995034669A2 Retroviral gene therapy vectors and therapeutic methods based thereon |
12/21/1995 | WO1995034668A2 The cytoplasmic inhibition of gene expression |
12/21/1995 | WO1995034667A2 Transformation of guar |
12/21/1995 | WO1995034661A1 Fas associated proteins |
12/21/1995 | WO1995034659A1 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
12/21/1995 | WO1995034656A1 Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
12/21/1995 | WO1995034654A1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator |
12/21/1995 | WO1995034651A2 Corticotropin-releasing factor2 receptors |
12/21/1995 | WO1995034638A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
12/21/1995 | WO1995034637A1 Method for selectively inducing biomarker expression in urologic tumor tissue for diagnosis and treatment thereof |
12/21/1995 | WO1995034636A1 Ungulate eg cell |
12/21/1995 | WO1995034634A2 Use of anthocyanin genes to maintain male sterile plants |
12/21/1995 | WO1995034580A1 Isolated nucleic acid encoding retinol dehydrogenase |
12/21/1995 | WO1995034578A1 Recombinant allergen, fragments thereof, corresponding recombinant dna molecules, vectors and hosts containing the dna molecules, diagnostic and therapeutic uses of said allergens and fragments |
12/21/1995 | WO1995034324A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
12/21/1995 | WO1995034319A1 Compositions and methods for the treatment of tumors |
12/21/1995 | WO1995034317A1 Growth factor preparation, its production and use |